Park Medi World Ltd

The stock debuted at Rs 155.60, marking a discount of 3.95% to the issue price. So far, the stock has hit a high of 161.75 and a low of 155.60. On the BSE, over 9.79 lakh shares of the company were traded in the counter so far. The initial public offer of Park Medi World was subscribed 8.10 times. The issue opened for bidding on 10 December 2025 and it closed on 12 December 2025. The price band of the IPO is fixed between Rs 154 and 162 per share. The IPO comprised a fresh issue of equity shares worth up to Rs 770 crore and an offer for sale aggregating up to Rs 150 crore by existing shareholder Dr. Ajit Gupta. The objectives of the fresh issue include Rs 380 crore for the repayment/prepayment of outstanding borrowings, Rs 60.5 crore for funding capital expenditure towards the development of a new hospital by the subsidiary Park Medicity (NCR), Rs 27.45 crore for the purchase of medical equipment by the company and its subsidiaries, Blue Heavens and Ratangiri, and the remaining amount for inorganic acquisitions and general corporate purposes. The promoters, Dr. Ajit Gupta and Dr. Ankit Gupta, and the promoter group hold an aggregate of 36,73,07,766 equity shares, aggregating 95.55% of the pre-offer issued and paid-up equity share capital. Their post-IPO shareholding is expected to be around 82.89%. Park Medi World is a leading private hospital chain in North India, with 3,250 beds (the largest in Haryana) across 14 NABH-accredited multi-super specialty hospitals. The company offers 30+ specialties, including internal medicine, neurology, urology, gastroenterology, orthopedics, and oncology, supported by 1,014 doctors and 2,142 nurses. It has expanded through acquisitions and is building new hospitals in Ambala, Panchkula, Rohtak, Gorakhpur, and Kanpur, aiming to increase total bed capacity to 4,900 by FY28. Revenue is led by internal medicine (29.65%) and supported mainly by government schemes (83.38%). Bed occupancy stands at 68.14%, with inpatient and outpatient volumes of 46,551 and 3,92,049 respectively. Ahead of the IPO, Park Medi World, on 9 December 2025, raised Rs 275.99 crore from anchor investors. The board allotted 1.70 crore shares at Rs 162 each to 23 anchor investors. The firm reported a consolidated net profit of Rs 139.14 crore and an income from operations of Rs 808.66 crore for the nine months ended on 31 June 2025.Powered by Capital Market - Live

The equity shares of Park Medi World (Scrip Code: 544645) are listed effective 17 December 2025 and admitted to dealings on the Exchange in the list of ''B'' Group Securities. At 09:13 IST, the pre-open indicative price of the stock was at a discount of 4.32% to the issue price of 162.Powered by Capital Market - Live